Eytan Breman is the Director of the R&D department at Celyad Oncology based in Belgium. He is an immunologist with degrees in engineering and a BA in Applied Biosciences from Zuyd University (the Netherlands); a Master degree in Biopharmaceutical Sciences from the University of Leiden (the Netherlands); and a PhD in transplant immunology from the University of Antwerp (Belgium). He first joined Celyad Oncology as an R&D Project Leader in 2015 and has since held positions as senior scientist and R&D Manager of the discovery group. As of June 2022, he became Head of the R&D department and transitioned Celyad Oncology from a clinical-stage company to a pre-clinical stage company, developing novel technologies and solutions to combat life-threatening diseases. Over the course of his career, he has been awarded multiple awards (such as the Anthony P. Monaco Award for his work in the transplant field in 2014); written dozens of publications; and filed a few dozen patents.